A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer von Cecchini, Michael, Kortmansky, Jeremy S., Cui, Can, Wei, Wei, Thumar, Jaykumar Ranchobdhai, Uboha, Nataliya V., Hafez, Navid, Lacy, Jill, Fischbach, Neal A., Sabbath, Kert D., Gomez, Christina M., Sporn, Jonathan Reed, Stein, Stacey, Hochster, Howard S.

Volltext